Tianjin Medical University
Also known as: 86-13752570372 | Affiliated Cancer Hospital of Tianjin Medical University | BangMao Wang | Breast Cancer Department I, Tianjin Medical University Cancer Institute and Hospital | Breast Oncology, Tianjin Medical University Cancer Institute and Hospital | Cancer Hospital of Tianjin Medical University | Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Hospital | Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital | Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital | Department of Pulmonary Medical Oncology, Tianjin Medical University Cancer Hospital | Department of Radiation Oncology, Tianjin Medical University Cancer Hospital | Fu-Dong Shi | General Hospital of Tianjin Medical University | Guolin Wang | Jiao Mingfei | National Clinical Research Center for Cancer of China | No. 261, Taierzhuang South Road, Jinnan District, Tianjin, Tianjin Chest Hospital. | Ophthalmology of Tianjin Medical University General Hospital | People's Hospital of Tianjin | Second Hospital of Tianjin Medical University | Shehzaad Joomye | Tainjin Medical University | Tainjin Medical University General Hospita | TB Institute, Tianjin | The General Hospital of Tianjin Medical University | The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine | The Third Central Clinical College of Tianjin Medical University | Tianjin | Tianjin Anding Hospital | Tianjin Beichen Hospital | Tianjin cancer hospital | Tianjin Cancer hospital | TIANJIN CANCER HOSPITAL | Tianjin Central Hospital of Gynecology Obstetrics | Tianjin Children's Hospital | Tianjin First Central Hospital | Tianjin First Hospital | Tianjing medical university | Tianjing medical university cancer hospital | TianJing Medical University Eye Hospital | Tianjing Medical University General Hospital | Tianjin Hematonosis Hospital | Tianjin infectious disease hospital | Tianjin Medical University | TianJin Medical University Affiliated Cancer Hospital | Tianjin Medical University Cancer | Tianjin Medical University Cancer Hospital | Tianjin Medical University Cancer Insitute & Hospital | Tianjin Medical University Cancer Institude and Hospital | Tianjin Medical University Cancer Institue and Hospital | Tianjin Medical University Cancer Institure and Hospital | Tianjin Medical University Cancer Institute and Hospital | Tianjin Medical University Cancer Institute & Hospital | Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Cancer | Tianjin Medical University Eye Hospital | Tianjin Medical University General Hospital | Tianjin Medical University Institute and Hospital | Tianjin Medical University Second Hospital | Tianjin Medical Unversity Second Hospital | Tianjin meidcal university general hospital,China | Tianjin People's Hospital | Tianjin Third Central Hospital | Xiaomin Zhang | Yuanyuan Zhang | Zhu Xianyi Memorial Hospital of Tianjin Medical University | 研究者
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2005Last known activity
Aug 31, 2027
Timeline
1950s
- Jan 1, 1951
Tianjin Medical University— Founded
Drugs by trial phase (383 distinct, 553 trials)
Phase 4 (83 own, 0 via acquisition)
Phase 3 (99 own, 0 via acquisition)
Phase 2 (113 own, 0 via acquisition)
Phase 1 (33 own, 0 via acquisition)
Other trials (55 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anemia
- Anemia, Aplastic
- Aneurysm
- Angina Pectoris
- Angina, Stable
- Anxiety Disorders
- Arteriosclerosis
- Arteriosclerosis Obliterans
- Astrocytoma
- Biliary Tract Neoplasms
- Blind Loop Syndrome
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Squamous Cell
- Cerebral Infarction
- Cervical Intraepithelial Neoplasia
- Cholangiocarcinoma
- Choroidal Neovascularization
- Colorectal Neoplasms
- Communicable Diseases
- Coronary Artery Disease
- Delayed Emergence from Anesthesia
- Dementia
- Depressive Disorder
- Diabetic Retinopathy
- Disease
- Disease Susceptibility
- Dwarfism, Pituitary
- Embolism
- Endocarditis
- Endocrine System Diseases
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Fallopian Tube Neoplasms
- Fatty Liver
- Gallbladder Neoplasms
- Gastritis
- Gastrointestinal Neoplasms
- Genetic Predisposition to Disease
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Healthcare-Associated Pneumonia
- Heart Failure
- Hematoma
- Hematoma, Subdural
- Hematoma, Subdural, Chronic
- Hemophilia A
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
- Hypertriglyceridemia
- Hypothyroidism
- Infarction
- Infections
- Inflammation
- Intraabdominal Infections
- Kidney Diseases
- Leukemia
- Leukemia, Large Granular Lymphocytic
- Lung Neoplasms
- Lymphatic Metastasis
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Major Depressive Disorder
- Metabolic Syndrome
- Metaplasia
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasms
- Neovascularization, Pathologic
- Neuromyelitis Optica
- Neurotoxicity Syndromes
- Neutropenia
- Non-alcoholic Fatty Liver Disease
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pancreatitis
- Parkinson Disease
- Peripheral Nervous System Diseases
- Pneumonia
- Postoperative Complications
- Precancerous Conditions
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Pulmonary Embolism
- Purpura
Recent trials (50)
- NCT07170293OfficialPhase 2Aug 31, 2027
- NCT07170293Lead sponsorPhase 2Aug 31, 2027
- NCT07277972Lead sponsorPhase 2Feb 15, 2026
- NCT07277972OfficialPhase 2Feb 15, 2026
- NCT07263360Lead sponsorPhase 2Feb 1, 2026
- NCT07302841Lead sponsorPhase 4Jan 20, 2026
- NCT07288749CollaboratorPhase 3Jan 1, 2026
- NCT07244926OfficialPhase 2Dec 31, 2025
- NCT07244926Lead sponsorPhase 2Dec 31, 2025
- NCT07272291Lead sponsorPhase 2Dec 25, 2025
- NCT07304739Lead sponsorPhase 2Dec 22, 2025
- NCT07304739OfficialPhase 2Dec 22, 2025
- NCT07307287Lead sponsorPhase 2Dec 20, 2025
- NCT07254416Lead sponsorPhase 4Dec 15, 2025
- NCT07246317Lead sponsorPhase 2Dec 15, 2025
Details
- Founded
- Tianjin, CN Jan 1, 1951
- Last known activity
- Aug 31, 2027